Owkin France
General information
Owkin France
12 Rue Martel
Ile-de-France
75010 Paris, Paris
France
Contact person: Philippe de Vomécourt, Strategy Manager
Website: https://owkin.com
12 Rue Martel
Ile-de-France
75010 Paris, Paris
France
Contact person: Philippe de Vomécourt, Strategy Manager
Website: https://owkin.com
| Source of foundation: | Subsidiary |
| Name of foundation source: | Owkin, USA |
Corporate description / mission:
Owkin uses artificial intelligence to find the right treatment for every patient. We use AI to identify new drug candidates, de-risk and accelerate clinical trials and build diagnostic tools that improve patient outcomes. Using federated learning, Owkin unlocks valuable insights from siloed datasets, while protecting patient privacy and securing proprietary data.
Owkin was co-founded by Thomas Clozel MD and Gilles Wainrib in 2016, and now works with the most prominent cancer centers and biopharma companies in Europe and the US. It has raised over $255 million, becoming a unicorn in November 2021
Owkin uses artificial intelligence to find the right treatment for every patient. We use AI to identify new drug candidates, de-risk and accelerate clinical trials and build diagnostic tools that improve patient outcomes. Using federated learning, Owkin unlocks valuable insights from siloed datasets, while protecting patient privacy and securing proprietary data.
Owkin was co-founded by Thomas Clozel MD and Gilles Wainrib in 2016, and now works with the most prominent cancer centers and biopharma companies in Europe and the US. It has raised over $255 million, becoming a unicorn in November 2021
State of ownership: Private / independent
Headquarters: No
Headquarters: No
Categorization
| Sector: |
|
| Subsector: |
|
| Business model: |
|
| Customer segments: |
|
Summary Products / Services / Technologies
Technology used:
OWKIN Socrates
OWKIN Socrates
© 2023 Biotechgate by Venture Valuation